Screener
Stoke Therapeutics, Inc. STOK Total Operating Expenses
Total Operating Expenses at other companies
Segments
By product
Other financials
Where this comes from
Reported directly by Stoke Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:OperatingExpenses.
The source filing: Stoke Therapeutics, Inc.’s 10-Q, filed May 7, 2026.
- Filed
- May 7, 2026, 4:06 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001193125-26-211874
| Line item | Three Months Ended March 31, 2026 | Three Months Ended March 31, 2025 |
|---|---|---|
| Operating expenses: | ||
| Research and development | 39,673 | 32,676 |
| Sales, general and administrative | 19,974 | 14,653 |
| Total operating expenses | 59,647 | 47,329 |
| (Loss) income from operations | (53,418) | 111,240 |
| Other income (expense): | ||
| Interest income (expense), net | 3,397 | 2,889 |
| Other income | 18 | 28 |
Item 1. Financial Statements.
FAQ
- What is Stoke Therapeutics, Inc.'s total operating expenses?
- Stoke Therapeutics, Inc. (STOK) reported total operating expenses of $59.65M in Q1 2026.
- How has Stoke Therapeutics, Inc.'s total operating expenses changed year-over-year?
- Stoke Therapeutics, Inc.'s total operating expenses increased by 26.0% year-over-year, from $47.33M to $59.65M.
- What is the long-term trend for Stoke Therapeutics, Inc.'s total operating expenses?
- Over 4 years (2021 to 2025), Stoke Therapeutics, Inc.'s total operating expenses has grown at a 24.2% compound annual growth rate (CAGR), from $86.07M to $205.01M.
- What does total operating expenses mean?
- The sum of all operating costs including COGS, SG&A, R&D, D&A, and other operating charges. Revenue minus total operating expenses equals operating income.
Ask your AI about Stoke Therapeutics, Inc.'s total operating expenses.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude